To determine if higher doses of IL‐1α‐MPs would potentially be safe, a single dose of rIL‐1α or IL‐1α‐MPs (7.5 and 15 μg, i.p.)was administered to tumor bearing mice (Figure 4a). Here, IL1A is linked to neoplasm.